These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2994109)
1. Challenges and opportunities in biotechnology. Overby LR Prog Clin Biol Res; 1985; 182():425-43. PubMed ID: 2994109 [TBL] [Abstract][Full Text] [Related]
2. Drug products of recombinant DNA technology. Black WJ Am J Hosp Pharm; 1989 Sep; 46(9):1834-44. PubMed ID: 2679063 [TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. Fish vaccine antigens produced or delivered by recombinant DNA technologies. Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855 [TBL] [Abstract][Full Text] [Related]
11. Research and development of drugs and biologic entities. Piascik MM Am J Hosp Pharm; 1991 Oct; 48(10 Suppl 1):S4-13. PubMed ID: 1772113 [TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. Schnittman SM; Fauci AS Adv Intern Med; 1994; 39():305-55. PubMed ID: 8140958 [TBL] [Abstract][Full Text] [Related]
13. Biotechnology: an introduction to recombinant DNA technology and product availability. Evens RP; Witcher M Ther Drug Monit; 1993 Dec; 15(6):514-20. PubMed ID: 8122286 [TBL] [Abstract][Full Text] [Related]
14. [Prospects and achievements of genetic engineering in development of antiviral vaccines]. Tikhonenko TI Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971 [TBL] [Abstract][Full Text] [Related]
15. [The significance of key technologies for the development of medicine]. von Baehr R Z Gesamte Hyg; 1989 Jun; 35(6):309-10. PubMed ID: 2800623 [TBL] [Abstract][Full Text] [Related]
16. Recombinant DNA technology for the preparation of subunit vaccines. Bachrach HL J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235 [TBL] [Abstract][Full Text] [Related]
17. Recombinant DNA manipulations and their interfaces with protein technology. Nagley P Dev Biol Stand; 1987; 67():171-6. PubMed ID: 3475224 [TBL] [Abstract][Full Text] [Related]
18. Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice. Piascik P Pharm Pract Manag Q; 1998 Jul; 18(2):1-12. PubMed ID: 10185234 [TBL] [Abstract][Full Text] [Related]
19. Biotechnology: alternatives to human plasma-derived therapeutic proteins. Lynch TJ Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):669-88. PubMed ID: 11102283 [TBL] [Abstract][Full Text] [Related]
20. Production and analysis of proteins by recombinant DNA technology. Pestka S Bioprocess Technol; 1990; 7():235-65. PubMed ID: 1366823 [No Abstract] [Full Text] [Related] [Next] [New Search]